Related Experiment Videos
Ethidium binding sites on plasmid DNA determined by photoaffinity labeling
The Journal of Biological Chemistry
|September 10, 1984
Summary
Photoaffinity labeling revealed ethidium binding to DNA. Ethidium monoazide (EMA) binding blocked restriction enzyme digestion, indicating sequence specificity, though not exclusively at GC-rich sites.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Ethidium bromide is a known DNA intercalator.
- Understanding ethidium's DNA binding specificity is crucial for its applications.
Purpose of the Study:
- To investigate the sequence specificity of ethidium binding to native DNA using photoaffinity labeling.
- To determine if ethidium preferentially binds to specific DNA sequences or GC-rich regions.
Main Methods:
- Photoaffinity labeling of pBR322 plasmid DNA with ethidium monoazide (EMA).
- Analysis of restriction enzyme digestion patterns after EMA labeling.
- Quantification of covalently linked EMA on DNA fragments.
- Determination of GC content for each DNA fragment.
Main Results:
- Covalent binding of EMA blocked restriction enzyme digestion, indicating sequence-specific binding.
- Drug binding could occur 2-3 base pairs away from the recognition site and still inhibit digestion.
- Approximately half of the DNA fragments showed preferential EMA binding to GC base pairs.
- No strict preference for specific sequences like 5'-CG-3' was observed; binding specificity may involve multiple DNA structural features.
Conclusions:
- Ethidium binding to DNA exhibits sequence specificity, evidenced by blocked restriction enzyme digestion.
- While GC content influences binding, it is not the sole determinant; other DNA structural features contribute to ethidium's binding specificity.